Poly(ADP-ribose) polymerase-1 Overexpression as A Predictive Factor for Poor Chemotherapy Outcome in Triple Negative Breast Cancer
Journal: International Journal of Science and Research (IJSR) (Vol.6, No. 11)Publication Date: 2017-11-05
Authors : Vika Indriani; Herman Saputra; Luh Putu Iin Indrayani Maker;
Page : 1881-1885
Keywords : triple negative breast cancer; chemotherapy clinical response; poly ADP-ribose polymerase-1;
Abstract
Triple-negative breast cancer (TNBC), is paradoxical breast cancer subtype. Some TNBC response well to chemotherapy but TNCB with remaining tumor mass after neoadjuvant chemotherapy have worse prognosis. Most TNBCs have defects in DNA repair pathway. To survive they activate alternative DNA repair pathway involving poly (ADP-ribose) polymerase-1 (PARP1), reflected by PARP1 overexpression. The aim of this study was to prove PARP1 overexpression as a predictive factor for poor chemotherapy outcome in TNBC. This study was conducted in retrospective case-control method. The PARP1 expressions immunohistochemically evaluated in 25 patients with positive chemotherapy clinical response and 25 patients with negative chemotherapy clinical response. The results were analyzed by Chi square and Odds ratio (OR) with significance at p
Other Latest Articles
- Potential Yield of Some Local Gogo Rice Varieties of North Sumatra and Aceh on Rainfed Rice Fields
- Energy Harvesting System for Wireless Sensor Nodes from Ambient Sources
- Attitudes of Students in West Siang District of Arunachal Pradesh towards Educated and Working Women
- Establishment of Local Reference for Left Liver Lobe Dimensions in Normal Sudanese School Age Children Using Ultrasonography
- Effect of Breaking Seed Dormancy Treatments on Germination and Vegetative Growth of Some Legumes Plant
Last modified: 2021-06-30 20:02:28